At the University of Leicester, a team of scientists has demonstrated a novel treatment for Hairy Cell Leukaemia (HCL), a rare type of blood cancer, using a drug administered to combat skin cancer.
Leukemia Treatment Takes a Step Closer to Reality Thanks to Artificial Bone Marrow
A prototype of artificial bone marrow has now been developed by scientists, which will be used to reproduce hematopoietic stem cells
A prototype of artificial bone marrow has now been developed by scientists, which will be used to reproduce hematopoietic stem cells
Dr Salvador Macip, from the University of Leicester's Department of Biochemistry, explained: "A genetic study of the patient's blood cells allowed us to identify a mutation in the BRAF gene that is commonly found in skin cancers. This knowledge enabled us to combat the cancer cells with Vemurafenib, which has had proven success as a BRAF inhibitor in melanomas, and showed similar success for this patient who had exhausted all other treatment options, which is fantastic.
Source-Eurekalert
Target of Potent Chronic Leukemia Drug Confirmed in New Study
A molecule targeted by the experimental drug ibrutinib is critical for the development of chronic lymphocytic leukemia, the most common form of adult leukemia.
A molecule targeted by the experimental drug ibrutinib is critical for the development of chronic lymphocytic leukemia, the most common form of adult leukemia.
Scientists Swat Aggressive Relapsing Leukemia
Scientists have developed a unique therapeutic strategy, using genetic information initially uncovered in fruit fly studies, that stops an aggressive and deadly form of leukemia in laboratory models of the disease.
Scientists have developed a unique therapeutic strategy, using genetic information initially uncovered in fruit fly studies, that stops an aggressive and deadly form of leukemia in laboratory models of the disease.
Improved Treatment for Leukemia Patients Possible With Help Of Systems Medicine
A novel individualized systems medicine (ISM) strategy which enables selection of potentially effective cancer therapies for individual patients was developed by researchers.
A novel individualized systems medicine (ISM) strategy which enables selection of potentially effective cancer therapies for individual patients was developed by researchers.
